Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ENERGY ACTION LIMITED Share Issue/Capital Change 2017

Mar 21, 2017

64812_rns_2017-03-21_07932b4b-9a9a-4205-bf44-a16040031ee7.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, Application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Energy Action Limited (EAX)

ABN

$\mathbf{I}$

90 137 363 636

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

+Class of +securities issued or to be issued

Performance Rights

Number of +securities issued or $\overline{2}$ to be issued (if known) or maximum number which may be issued

104,236

Principal terms of the $\overline{\mathbf{3}}$ +securities $(e.g.$ if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment: if the +convertible securities. conversion price and dates for conversion)

Exercise price: nil

Vesting Dates: 104,236 may vest on 31 August 2019

Vesting is subject to performance and service conditions

Appendix 3B Page 1

+ See chapter 19 for defined terms.

$\hat{\boldsymbol{\tau}}$

$\overline{4}$ Do the +securities rank equally
in all respects from the +issue
date with an existing +class of
quoted +securities?
If the additional +securities do
not rank equally, please state:
No.
Any share allocated on the vesting of a
Performance Right will rank equally with
existing ordinary shares.
the date from which they do
which
the
extent
to
they
for
the
participate
next
dividend, (in the case of a trust,
distribution)
interest

payment
the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
5 Issue price or consideration Nil
6 Purpose of the issue
(If issued as consideration for
the acquisition of assets, clearly
identify those assets)
Issued under the Energy Action Performance
Rights and Options Plan.
6a Is the entity an $\dagger$ eligible entity
obtained
has
that
security
holder approval under rule 7.1A?
Yes
If Yes, complete sections 6b - 6h
in relation to the + securities the
subject of this Appendix 3B, and
comply with section 6i
6b The date the security holder
resolution under rule 7.1A was
passed
10 November 2016
Number of + securities issued
without security holder approval
n/a

04/03/2013

+ See chapter 19 for defined terms.

  • 6d Number of +securities issued with security holder approval under rule 7.1A
  • Number of +securities issued 6e with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting).
  • Number of +securities issued 6f under an exception in rule 7.2
  • If *securities issued under rule $6g$ 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.
  • If +securities were issued under $\mid$ n/a $6h$ for non-cash rule $7.1A$ consideration, state date on which valuation of consideration was released to ASX Market Announcements
  • 6i Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

+Issue dates $\overline{7}$

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

8 Number and +class of al *securities quoted on ASY (including the +securities in section 2 if applicable)

Number + Class
25,954,117 Ordinary fully paid
shares

$n/a$

$n/a$

104,236

$n/a$

Under 7.1 - 3,893,118

Under 7.1A - 2,595,411

13 March 2017

  • See chapter 19 for defined terms.

Appendix 3B Page 3

Appendix 3B
New issue announcement

Number + Class
Number and + class of all
+ securities not quoted on ASX
(including the + securities in
section 2 if applicable)
507,885 Performance Rights
10 Dividend policy (in the case of a $\vert$
trust, distribution policy) on the
increased capital (interests)
As per existing issued shares

Part 2 - Pro rata issue

11 security holder
approval
Is
required?
n/a
12 Is the issue renounceable or non-
renounceable?
n/a
13 Ratio in which the + securities
will be offered
n/a
14 + Class of + securities to which the
offer relates
n/a
15 +Record
date
determine
to
entitlements
n/a
16 different
Will
holdings
on
registers (or subregisters) be
aggregated
for
calculating
entitlements?
n/a
17 Policy for deciding entitlements
in relation to fractions
n/a
18 Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
n/a
Cross reference: rule 7.7.
19 Closing date for receipt
of
acceptances or renunciations
n/a

$\sim$

  • See chapter 19 for defined terms.

Appendix 3B
New issue announcement

20 Names of any underwriters n/a
21 Amount of any underwriting fee
or commission
n/a
22 Names of any brokers to the
issue
n/a
23 Fee or commission payable to the
broker to the issue
$\eta$
n/a
24 Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
n/a
25 If the issue is contingent on
security holders' approval, the
date of the meeting
n/a
26 Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
n/a
27 If the entity has issued options,
and the terms entitle option
holders
participate
to
on
exercise, the date on which
notices will be sent to option
holders
n/a
28 Date rights trading will begin (if
applicable)
n/a
29 Date rights trading will end (if
applicable)
n/a
30 How do security holders sell
their entitlements in full through
a broker?
n/a
31 How do security holders sell part
of their entitlements through a
broker
and
accept
for the
balance?
n/a

Appendix 3B Page 5

+ See chapter 19 for defined terms.

Appendix 3B New issue announcement

How do security holders dispose $\dot{3}2$ of their entitlements (except by sale through a broker)?

$n/a$

+Issue date 33

n/a

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • Type of +securities 34 (tick one)
  • $(a)$

$(b)$

+Securities described in Part 1 Γxι

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • If the 'securities are 'equity securities, the names of the 20 largest holders of the 35 additional +securities, and the number and percentage of additional +securities held by those holders
  • If the *securities are *equity securities, a distribution schedule of the additional 36 *securities setting out the number of holders in the categories $1 - 1,000$ $1,001 - 5,000$ $5,001 - 10,000$ 10,001 - 100,000 100,001 and over

37

A copy of any trust deed for the additional +securities

Entities that have ticked box 34(b)

$38$ Number of +securities for which +quotation is sought

+ See chapter 19 for defined terms.

Appendix 3B New issue announcement

Quotation agreement

  • $\mathbf{1}$ +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the *securities on any conditions it decides.
  • We warrant the following to ASX. $\overline{\mathbf{2}}$
  • The issue of the 'securities to be quoted complies with the law and is not for an illegal purpose.

+ See chapter 19 for defined terms.

  • There is no reason why those 'securities should not be granted +quotation.
  • An offer of the 'securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any 'securities to be quoted and that no-one has any right to return any 'securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the 'securities be quoted.
  • If we are a trust, we warrant that no person has the right to return the *securities to be quoted under section 1019B of the Corporations Act at the time that we request that the 'securities be quoted.
  • We will indemnify ASX to the fullest extent permitted by law in respect of any $\overline{\mathbf{3}}$ claim, action or expense arising from or connected with any breach of the warranties in this agreement.
  • We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here:

$\overline{4}$

Date: $22/3/17$

Print name:

CAROLYN WEST

04/03/2013

+ See chapter 19 for defined terms.

Appendix 3B - Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule $7.1$ – Issues exceeding 15% of capital
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
Add the following:
Number of fully paid +ordinary securities
issued in that 12 month period under an
exception in rule 7.2
Number of fully paid + ordinary securities
issued in that 12 month period with
shareholder approval
Number of partly paid +ordinary
٠
securities that became fully paid in that
12 month period
Note:
Include only ordinary securities here -
other classes of equity securities cannot
be added
Include here (if applicable) the securities
$\bullet$
the subject of the Appendix 3B to which
this form is annexed
It may be useful to set out issues of
$\bullet$
securities on different dates as separate
line items
Subtract the number of fully paid +ordinary
securities cancelled during that 12 month
period
"A" 25,954,117
  • See chapter 19 for defined terms.

$\bar{\boldsymbol{\lambda}}$

Step 2: Calculate 15% of "A"
"B" 0.15
[Note: this value cannot be changed]
Multiply "A" by 0.15 3,893,118
Step 3: Calculate "C", the amount of placement capacity under rule
7.1 that has already been used
Insert number of + equity securities issued
or agreed to be issued in that 12 month
period not counting those issued:
Under an exception in rule 7.2
Under rule 7.1A
With security holder approval under rule
7.1 or rule 7.4
Note:
This applies to equity securities, unless
specifically excluded - not just ordinary
securities
Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
It may be useful to set out issues of
٠
securities on different dates as separate
line items
"C"
Step 4: Subtract "C" from ["A" x "B"] to calculate remaining
placement capacity under rule 7.1
"A" x 0.15 3,893,118
Note: number must be same as shown in
Step 2
Subtract"C"

Note: number must be same as shown in Step 3

3,893,118

[Note: this is the remaining placement
capacity under rule 7.1]

Total ["A" $\times$ 0.15] $\neg$ "C"

+ See chapter 19 for defined terms.

Ē,

$\ddot{\phantom{a}}$

Part 2

$\overline{1}$

Rule 7.1A - Additional placement capacity for eligible entities
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
"А" 25,954,117
Note: number must be same as shown in
Step 1 of Part 1
Step 2: Calculate 10% of "A"
"D" 0.10
Note: this value cannot be changed
Multiply "A" by 0.10 2,595,411
Step 3: Calculate "E", the amount of placement capacity under rule
7.1A that has already been used
Insert number of + equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Nil
Notes:
This applies to equity securities - not
just ordinary securities
Include here $-$ if applicable $-$ the
٠
securities the subject of the Appendix
3B to which this form is annexed
Do not include equity securities issued
٠
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
It may be useful to set out issues of
٠
securities on different dates as separate
line items
"E" Nil

$\mathcal{L}$

+ See chapter 19 for defined terms.

Appendix 3B New issue announcement

$\lambda$

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining
placement capacity under rule 7.1A
"A" x 0.10 2,595,411
Note: number must be same as shown in
Step 2
Subtract "E" Nil
Note: number must be same as shown in
Step 3
Total ["A" $\times$ 0.10] – "E" 2,595,411
Note: this is the remaining placement
capacity under rule 7.1A

$\frac{1}{2}$

+ See chapter 19 for defined terms.